BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2017
View Archived Issues
Frequency Therapeutics announces closing of series A financing
Read More
Inovio Pharmaceuticals reports initial results from phase I study of Ebola vaccine
Read More
Appili Therapeutics receives funding from Canadian government to develop antibiotic
Read More
FDA grants reactivation status for MARVEL phase II/III trial
Read More
Preclinical characterization of the novel adenosine A2A receptor inhibitor AZD-4635
Read More
LTT Bio-Pharma reports results of phase II clinical trial for LT-4002
Read More
Positive topline results from phase II trial of SB-208
Read More
Janssen develops promising tau PET tracer JNJ-067
Read More
First patient treated in METROmaJX study of Pexa-Vec
Read More
New Alzheimer's disease model uses hearing impairment to assess progression
Read More
BioCryst Pharmaceuticals announces plans to test oral liquid formulation of BCX-7353
Read More
KNOW Bio Respiratory changes name to Novoclem Therapeutics
Read More
Ironshore announces plans for two pivotal studies of HLD-100
Read More
First clinical study of gastrin analogue CP-04 as a theranostic for medullary thyroid carcinoma
Read More
XOMA tests anti-PTH1R human monoclonal antibodies in vitro and in rodent models
Read More
Positive phase III 6-month topline safety and efficacy results from Rocket-4 study of Rhopressa
Read More
Araxes Pharma discloses novel RAS family inhibitors
Read More
Siemens Healthineers receives HSS funding for the development of novel Zika diagnostic test
Read More
Taisho Pharmaceutical patents orexin receptor antagonists
Read More
Novel MALT1 inhibitors identified at Toray Industries
Read More
Roche launches diagnostic antibody to help distinguish morphologically difficult prostate cancers
Read More
Concert Pharmaceuticals discovers new CFTR potentiators
Read More
Sichuan Haisco Pharmaceutical discloses new muscarinic receptor antagonists
Read More
Jagiellonian University and collaborators patent 5-HT6 receptor antagonists
Read More
Shionogi applies for manufacture and sales approval for lisdexamfetamine dimesylate in Japan
Read More
GlaxoSmithKline initiates first-in-human trial of GSK-3036656
Read More
Patient enrollment begins in phase III AURORA trial of cenicriviroc
Read More
Mayo Clinic initiates phase I trial of VSV-hIFNbeta-NIS
Read More